NAMPT and glioma: Other therapeutic strategies exploiting potential metabolic vulnerabilities in IDH1mut gliomas, including inhibitors of poly (ADP-ribose) polymerase and nicotinamide phosphoribosyltransferase, are also being pursued [29–31].